Literature DB >> 21854569

Squamous cell carcinoma (Marjolin's ulcer) in an orocutaneous fistula of a large mandibular ameloblastoma: a case report.

Peter M Nthumba1.   

Abstract

INTRODUCTION: Ameloblastomas are rare lesions constituting 1% of all jaw tumors. Oral squamous cell carcinomas are common lesions; these constitute about 90% of all oral cancers. Concurrent tumors consisting of ameloblastoma and squamous cell carcinoma are extremely rare. CASE
PRESENTATION: This case report describes a 35-year-old African man who presented with a large mandibular tumor with an orocutaneous fistula that was found to be an ameloblastoma on histopathological examination, with concurrent squamous cell carcinoma histology within the fistula. This presentation was consistent with a Marjolin's ulcer within an ameloblastoma.
CONCLUSION: Ameloblastomas and Marjolin's ulcers require different management strategies. Careful histopathological examination of surgical specimens is key to patient outcome, as treatment of these patients depends on an accurate diagnosis.

Entities:  

Year:  2011        PMID: 21854569      PMCID: PMC3173382          DOI: 10.1186/1752-1947-5-396

Source DB:  PubMed          Journal:  J Med Case Rep        ISSN: 1752-1947


  10 in total

1.  Mandibular intraosseous carcinoma coexisting with ameloblastoma.

Authors:  H Hamakawa; H Kayahara; T Sumida; H Tanioka
Journal:  J Oral Maxillofac Surg       Date:  2000-04       Impact factor: 1.895

2.  Simultaneous occurrence of a squamous cell carcinoma and an ameloblastoma in the maxilla.

Authors:  T Nishimura; R Nagakura; A Ikeda; S Kita
Journal:  J Oral Maxillofac Surg       Date:  2000-11       Impact factor: 1.895

Review 3.  Marjolin's ulcers in sub-Saharan Africa.

Authors:  Peter M Nthumba
Journal:  World J Surg       Date:  2010-10       Impact factor: 3.352

4.  Intraosseous carcinoma arising from mandibular ameloblastoma with progressive invasion and pulmonary metastasis.

Authors:  E Ueta; K Yoneda; A Ohno; T Osaki
Journal:  Int J Oral Maxillofac Surg       Date:  1996-10       Impact factor: 2.789

5.  Simultaneous occurrence of an ameloblastoma and a squamous cell carcinoma of the mandible.

Authors:  M R Tucker; R W Dechamplain; J H Jarrett
Journal:  J Oral Maxillofac Surg       Date:  1984-02       Impact factor: 1.895

Review 6.  Common oral lesions: Part II. Masses and neoplasia.

Authors:  Wanda C Gonsalves; Angela C Chi; Brad W Neville
Journal:  Am Fam Physician       Date:  2007-02-15       Impact factor: 3.292

Review 7.  Are we on the brink of nonsurgical treatment for ameloblastoma?

Authors:  John J Sauk; Nikolaos G Nikitakis; Mark A Scheper
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2010-04-24

Review 8.  Mandibular ameloblastoma: clinical experience and literature review.

Authors:  Eric Sham; James Leong; Rory Maher; Michael Schenberg; Michael Leung; Alan K Mansour
Journal:  ANZ J Surg       Date:  2009-10       Impact factor: 1.872

9.  Segmental mandibulectomy and immediate free fibula osteoseptocutaneous flap reconstruction with endosteal implants: an ideal treatment method for mandibular ameloblastoma.

Authors:  Jagdeep S Chana; Yang-Ming Chang; Fu-Chan Wei; Yu-Fen Shen; Chiu-Po Chan; Hsiu-Na Lin; Chi-Ying Tsai; Seng-Feng Jeng
Journal:  Plast Reconstr Surg       Date:  2004-01       Impact factor: 4.730

10.  Marjolin's ulcers: theories, prognostic factors and their peculiarities in spina bifida patients.

Authors:  Peter M Nthumba
Journal:  World J Surg Oncol       Date:  2010-12-05       Impact factor: 2.754

  10 in total
  2 in total

1.  The effectiveness and safety of X-PDT for cutaneous squamous cell carcinoma and melanoma.

Authors:  Lei Shi; Pei Liu; Jing Wu; Lun Ma; Han Zheng; Michael P Antosh; Haiyan Zhang; Bo Wang; Wei Chen; Xiuli Wang
Journal:  Nanomedicine (Lond)       Date:  2019-06-05       Impact factor: 5.307

2.  Palliative reconstructive surgery: contextualizing palliation in resource-poor settings.

Authors:  Peter M Nthumba
Journal:  Plast Surg Int       Date:  2014-10-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.